Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells.

TitleCharacterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells.
Publication TypeJournal Article
Year of Publication2018
AuthorsLong J, Hoban MD, Cooper AR, Kaufman ML, Kuo CY, Campo-Fernandez B, Lumaquin D, Hollis RP, Wang X, Kohn DB, Romero Z
JournalMol Ther
Volume26
Issue2
Pagination468-479
Date Published2018 02 07
ISSN1525-0024
Keywordsbeta-Globins, Gene Conversion, Gene Editing, Gene Rearrangement, Gene Targeting, Genetic Variation, Hematopoietic Stem Cells, High-Throughput Nucleotide Sequencing, Humans, Nucleic Acid Amplification Techniques, Translocation, Genetic
Abstract

The use of engineered nucleases combined with a homologous DNA donor template can result in targeted gene correction of the sickle cell disease mutation in hematopoietic stem and progenitor cells. However, because of the high homology between the adjacent human β- and δ-globin genes, off-target cleavage is observed at δ-globin when using some endonucleases targeted to the sickle mutation in β-globin. Introduction of multiple double-stranded breaks by endonucleases has the potential to induce intergenic alterations. Using a novel droplet digital PCR assay and high-throughput sequencing, we characterized the frequency of rearrangements between the β- and δ-globin paralogs when delivering these nucleases. Pooled CD34 cells and colony-forming units from sickle bone marrow were treated with nuclease only or including a donor template and then analyzed for potential gene rearrangements. It was observed that, in pooled CD34 cells and colony-forming units, the intergenic β-δ-globin deletion was the most frequent rearrangement, followed by inversion of the intergenic fragment, with the inter-chromosomal translocation as the least frequent. No rearrangements were observed when endonuclease activity was restricted to on-target β-globin cleavage. These findings demonstrate the need to develop site-specific endonucleases with high specificity to avoid unwanted gene alterations.

DOI10.1016/j.ymthe.2017.11.001
Alternate JournalMol. Ther.
PubMed ID29221806
PubMed Central IDPMC5835144
Grant ListR25 GM055052 / GM / NIGMS NIH HHS / United States